Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
Anasthesie, Intensivtherapie, Notfallmedizin|June 1, 1989
[Monitoring infection at the intensive care unit--a multicenter pilot study]F Lackner, G Wewalka, M Rotter, et al.
Molecular Biology of the Cell|September 15, 2007
Direct repression of cyclin D1 by SIP1 attenuates cell cycle progression in cells undergoing an epithelial mesenchymal transitionJakob Mejlvang, Marina Kriajevska, Cindy Vandewalle, et al.
Current Cancer Drug Targets|August 28, 2012
Inhibition of STAT signalling in bladder cancer by diindolylmethane: relevance to cell adhesion, migration and proliferationYiyang Sun, Mai-Kim Cheng, Thomas R L Griffiths, et al.
The Journal of Pathology|February 22, 2002
Expression of S100A4 protein is associated with metastasis and reduced survival in human bladder cancerBarry R Davies, Marie O'Donnell, Garrett C Durkan, et al.
Molecular and Cellular Biology|October 4, 2005
Immediate and delayed effects of E-cadherin inhibition on gene regulation and cell motility in human epidermoid carcinoma cellsHenriette Andersen, Jakob Mejlvang, Shaukat Mahmood, et al.
The Journal of Invasive Cardiology|April 4, 2000
Determination of blood flow and endothelial shear stress in human coronary artery in vivoO J Ilegbusi, Z Hu, R Nesto, et al.
The American Journal of Pathology|February 13, 2002
Transfection of S100A4 produces metastatic variants of an orthotopic model of bladder cancerDiana Levett, Paul A Flecknell, Philip S Rudland, et al.
Experimental Cell Research|December 5, 2006
Characterization of E-cadherin-dependent and -independent events in a new model of c-Fos-mediated epithelial-mesenchymal transitionJakob Mejlvang, Marina Kriajevska, Fedor Berditchevski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Alteration in urinary matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio predicts recurrence in nonmuscle-invasive bladder cancerGarrett C Durkan, Joyce E Nutt, Colin Marsh, et al.
International Journal of Oncology|March 17, 2009
Lapatinib, a dual inhibitor of ErbB-1/-2 receptors, enhances effects of combination chemotherapy in bladder cancer cellsLynsey A McHugh, A Emre Sayan, Jakob Mejlvang, et al.
Pageof 11